drugset / Trial / NCT05581992

Study to Evaluate the Drug-drug Interaction Effect of Omeprazole on the Pharmacokinetics (PK) of AMG 510 in Healthy Participants

NCT05581992

Phase 1 Completed 14 enrolled Amgen
NaSingle-groupOpen-labelBasic science

Summary

The primary objective of this study is to evaluate the PK profile of AMG 510 alone and in combination with omeprazole in healthy participants.

Timeline

Start
2020-01-06
Primary completion
2020-01-26
Completion
2020-01-26

Drugs

EvaluationDrugModalityDoseRoute
Subject Omeprazole Other / unclassified
Subject Sotorasib Small molecule Oral

Indications

No indication recorded.